NM_003465.3:c.1060G>A

Variant summary

Our verdict is Benign. The variant received -19 ACMG points: 1P and 20B. PP3BP4_StrongBP6_Very_StrongBA1

The NM_003465.3(CHIT1):​c.1060G>A​(p.Gly354Arg) variant causes a missense change. The variant allele was found at a frequency of 0.00451 in 1,613,924 control chromosomes in the GnomAD database, including 268 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.024 ( 133 hom., cov: 33)
Exomes 𝑓: 0.0025 ( 135 hom. )

Consequence

CHIT1
NM_003465.3 missense

Scores

10
5
3

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts U:1B:3

Conservation

PhyloP100: 7.10

Publications

18 publications found
Variant links:
Genes affected
CHIT1 (HGNC:1936): (chitinase 1) Chitotriosidase is secreted by activated human macrophages and is markedly elevated in plasma of Gaucher disease patients. The expression of chitotriosidase occurs only at a late stage of differentiation of monocytes to activated macrophages in culture. Human macrophages can synthesize a functional chitotriosidase, a highly conserved enzyme with a strongly regulated expression. This enzyme may play a role in the degradation of chitin-containing pathogens. Several alternatively spliced transcript variants have been described for this gene. [provided by RefSeq, Jan 2012]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -19 ACMG points.

PP3
Multiple lines of computational evidence support a deleterious effect 9: AlphaMissense, BayesDel_noAF, Cadd, Dann, Eigen, MutationAssessor, PROVEAN, REVEL, REVEL [when max_spliceai, FATHMM_MKL, MetaRNN, MutationTaster was below the threshold]
BP4
Computational evidence support a benign effect (MetaRNN=0.008951932).
BP6
Variant 1-203217835-C-T is Benign according to our data. Variant chr1-203217835-C-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 472285.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0796 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CHIT1NM_003465.3 linkc.1060G>A p.Gly354Arg missense_variant Exon 10 of 11 ENST00000367229.6 NP_003456.1 Q13231-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CHIT1ENST00000367229.6 linkc.1060G>A p.Gly354Arg missense_variant Exon 10 of 11 1 NM_003465.3 ENSP00000356198.1 Q13231-1

Frequencies

GnomAD3 genomes
AF:
0.0236
AC:
3591
AN:
152206
Hom.:
132
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0817
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00903
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000414
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.000426
Gnomad OTH
AF:
0.0172
GnomAD2 exomes
AF:
0.00619
AC:
1547
AN:
250120
AF XY:
0.00437
show subpopulations
Gnomad AFR exome
AF:
0.0832
Gnomad AMR exome
AF:
0.00424
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0000464
Gnomad NFE exome
AF:
0.000212
Gnomad OTH exome
AF:
0.00295
GnomAD4 exome
AF:
0.00251
AC:
3663
AN:
1461600
Hom.:
135
Cov.:
34
AF XY:
0.00224
AC XY:
1630
AN XY:
727084
show subpopulations
African (AFR)
AF:
0.0854
AC:
2858
AN:
33474
American (AMR)
AF:
0.00483
AC:
216
AN:
44678
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26128
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39694
South Asian (SAS)
AF:
0.000476
AC:
41
AN:
86216
European-Finnish (FIN)
AF:
0.0000187
AC:
1
AN:
53392
Middle Eastern (MID)
AF:
0.00785
AC:
45
AN:
5736
European-Non Finnish (NFE)
AF:
0.000143
AC:
159
AN:
1111918
Other (OTH)
AF:
0.00568
AC:
343
AN:
60364
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.468
Heterozygous variant carriers
0
199
398
598
797
996
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
88
176
264
352
440
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0237
AC:
3611
AN:
152324
Hom.:
133
Cov.:
33
AF XY:
0.0222
AC XY:
1657
AN XY:
74492
show subpopulations
African (AFR)
AF:
0.0819
AC:
3404
AN:
41556
American (AMR)
AF:
0.00901
AC:
138
AN:
15308
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5178
South Asian (SAS)
AF:
0.000414
AC:
2
AN:
4826
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10626
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.000426
AC:
29
AN:
68038
Other (OTH)
AF:
0.0175
AC:
37
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.496
Heterozygous variant carriers
0
169
338
506
675
844
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
42
84
126
168
210
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00846
Hom.:
173
Bravo
AF:
0.0273
ESP6500AA
AF:
0.0783
AC:
345
ESP6500EA
AF:
0.000349
AC:
3
ExAC
AF:
0.00763
AC:
926
EpiCase
AF:
0.000109
EpiControl
AF:
0.000416

ClinVar

Significance: Benign/Likely benign
Submissions summary: Uncertain:1Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Uncertain:1Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Dec 16, 2015
Mayo Clinic Laboratories, Mayo Clinic
Significance:Uncertain significance
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Chitotriosidase deficiency Benign:2
Nov 18, 2019
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Apr 27, 2017
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to determine this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.90
BayesDel_addAF
Uncertain
0.096
D
BayesDel_noAF
Pathogenic
0.43
CADD
Pathogenic
27
DANN
Pathogenic
1.0
DEOGEN2
Uncertain
0.50
D;.
Eigen
Pathogenic
0.75
Eigen_PC
Uncertain
0.56
FATHMM_MKL
Pathogenic
0.97
D
LIST_S2
Uncertain
0.95
D;D
MetaRNN
Benign
0.0090
T;T
MetaSVM
Benign
-0.34
T
MutationAssessor
Pathogenic
4.8
H;.
PhyloP100
7.1
PrimateAI
Uncertain
0.55
T
PROVEAN
Pathogenic
-7.1
D;D
REVEL
Pathogenic
0.87
Sift
Pathogenic
0.0
D;D
Sift4G
Pathogenic
0.0
D;D
Polyphen
1.0
D;.
Vest4
0.96
MutPred
0.91
Gain of MoRF binding (P = 0.0162);.;
MVP
0.97
MPC
0.54
ClinPred
0.11
T
GERP RS
3.8
Varity_R
0.98
gMVP
0.96
Mutation Taster
=45/55
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs9943208; hg19: chr1-203186963; API